14-day Premium Trial Subscription Try For FreeTry Free
FRA:BV3
Delisted

Bavarian Nordic A/S Stock Price (Quote)

Frankfurt Stock Exchange
Open Broker Account
20.64€
+0 (+0%)
At Close: Dec 22, 2023
Forecast Insider Trading Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days 20.64€ 20.64€ Friday, 22nd Dec 2023 BV3.F stock ended at 20.64€. During the day the stock fluctuated 0% from a day low at 20.64€ to a day high of 20.64€.
90 days 20.18€ 21.17€
52 weeks 18.20€ 35.60€

Historical Bavarian Nordic A/S prices

Date Open High Low Close Volume
Jun 30, 2023 26.28€ 26.37€ 26.28€ 26.37€ 0
Jun 29, 2023 26.47€ 26.47€ 25.92€ 25.92€ 0
Jun 28, 2023 25.97€ 26.10€ 25.97€ 26.10€ 0
Jun 27, 2023 26.09€ 26.09€ 26.09€ 26.09€ 0
Jun 26, 2023 27.20€ 27.20€ 27.11€ 27.11€ 0
Jun 23, 2023 27.87€ 27.87€ 26.93€ 26.93€ 0
Jun 22, 2023 27.15€ 27.39€ 27.15€ 27.39€ 0
Jun 21, 2023 27.15€ 27.59€ 27.15€ 27.59€ 0
Jun 20, 2023 27.40€ 27.80€ 27.35€ 27.35€ 0
Jun 19, 2023 27.31€ 27.31€ 27.31€ 27.31€ 0
Jun 16, 2023 28.49€ 28.70€ 28.12€ 28.12€ 0
Jun 15, 2023 28.96€ 28.96€ 27.95€ 27.95€ 0
Jun 14, 2023 29.65€ 29.65€ 28.42€ 28.42€ 0
Jun 13, 2023 29.46€ 29.46€ 29.28€ 29.42€ 0
Jun 12, 2023 28.41€ 28.85€ 28.41€ 28.85€ 0
Jun 09, 2023 28.22€ 28.22€ 27.68€ 27.68€ 0
Jun 08, 2023 26.78€ 27.49€ 26.78€ 27.49€ 20
Jun 07, 2023 26.77€ 27.34€ 26.77€ 27.34€ 0
Jun 06, 2023 26.45€ 26.70€ 26.45€ 26.70€ 0
Jun 05, 2023 26.21€ 26.26€ 25.61€ 25.61€ 0
Jun 02, 2023 25.64€ 25.90€ 25.64€ 25.85€ 0
Jun 01, 2023 25.20€ 25.20€ 25.20€ 25.20€ 0
May 31, 2023 24.76€ 24.94€ 24.76€ 24.81€ 0
May 30, 2023 25.38€ 25.71€ 25.38€ 25.46€ 0
May 29, 2023 25.61€ 25.61€ 25.61€ 25.61€ 0
Click to get the best stock tips daily for free!

About Bavarian Nordic A/S

Bavarian Nordic A/S Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,... BV3.F Profile

Golden Star

Ticker Date Change Price
BSCQ Apr 30 0.393% $19.09
EQC Apr 30 1.76% $18.72
HRB Apr 30 1.69% $47.23
REG Apr 30 1.35% $59.22
INGR Apr 30 0.576% $114.59
BSJP Apr 29 0.175% $22.91
LYG Apr 29 0.781% $2.56
ORA Apr 29 3.46% $64.48
DHT Apr 24 4.34% $11.28
LPLA Apr 19 2.62% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT